期刊文献+

缝隙连接蛋白26和核转录因子κB在三阴性乳腺癌原发灶及淋巴结转移灶中的表达及临床意义 被引量:7

Expression levels of connexin 26 and NF-κB in primary lesion and metastatic lymph nodes of triple negative breast cancer,and its clinical significance
下载PDF
导出
摘要 目的:探讨缝隙连接蛋白26(connexin 26,Cx26)和核转录因子κB(nuclear factorκB,NF-κB)在三阴性乳腺癌(triple negative breast cancer,TNBC)病人原发灶和淋巴结转移灶中的表达及临床意义。方法:回顾性收集经术后病理和分子分型确诊为TNBC的存档石蜡组织,原发灶共49例,其中无区域淋巴结转移者22例(A1组),有区域淋巴结转移者27例(A2组);将27例淋巴结转移灶作为B组。应用免疫组织化学SP染色法,检测各组中Cx26和NF-κB的表达情况,并分析二者表达的相互关系及其与临床病理特征的相关性。结果:原发灶中A2组Cx26和NF-κB阳性表达率均高于A1组(P<0.01和P<0.05);转移灶B组Cx26和NF-κB阳性表达率均高于原发灶A1组(P<0.01)。Cx26蛋白表达与TNBC病人绝经状态、淋巴结转移有关(P<0.01),NF-κB表达与pTNM分期、淋巴结转移有关(P<0.01和P<0.05)。在淋巴结转移灶中,Cx26与NF-κB表达呈明显正相关关系(r=0.663,P<0.01)。结论:Cx26和NF-κB共同参与TNBC的浸润和转移,可作为预测TNBC转移复发及评估临床预后的有效指标。 Objective:To investigate the expression levels of connexin 26(Cx26) and nuckar factor κB(NF-κB) in primary lesion and metastatic lymph nodes of triple negative breast cancer(TNBC),and its clinical significance.Methods:The TNBC paraffin tissues diagnosed by postoperative pathology and molecular classification were collected.Forty-nine cases of primary lesions and 27 cases of lymph nodes metastatic lesions were divided into group A and group B,respectively.Group A included 22 cases without regional lymph node metastasis(group A1) and 27 cases with regional lymph node metastasis(group A2).The expression levels of Cx26 and NF-κB in all cases were examined using immunohistochemical staining.The relationship between Cx26 and NF-κB,and their correlations with clinical features were analyzed.Results:The positive expression rates of Cx26 and NF-κB in group A2 were higher than those in group A1(P<0.01 and P<0.05).The positive expression rates of Cx26 and NF-κB in group B were higher those in group A1(P<0.01).The expression level of Cx26 was correlated with the menopause state and lymph node metastasis(P<0.01),and the NF-κB level was correlated with pTNM staging and lymph node metastasis(P<0.01 and P<0.05).In lymph nodes metastatic lesions,the expression of Cx26 was positively correlated with the expression of NF-κB(P<0.01).Conclusions:Cx26 and NF-κB may co-participate in the invasion and metastasis of TNBC,and can be used as an effective indicator to predict TNBC metastasis and recurrence and evaluate clinical prognosis.
作者 刘圆圆 刘娟 杨燕 张金莲 巩幼洁 欧玉荣 LIU Yuan-yuan;LIU Juan;YANG Yan;ZHANG Jin-lian;GONG You-jie;OU Yu-rong(Department of Pathology,The First Affiliated Hospital of Bengbu Medical College,Bengbu Anhui 233004;Electrocardiogram Room,Xuecheng District People's Hospital,Zaozhuang Shandong 277000;Department of Medical Oncology,The First Affiliated Hospital of Bengbu Medical College,Bengbu Anhui 233004;Department of Pathology,The Second Affiliated Hospital of Bengbu Medical College,Bengbu Anhui,China)
出处 《蚌埠医学院学报》 CAS 2019年第11期1453-1457,共5页 Journal of Bengbu Medical College
基金 安徽省教育厅自然科学研究重点项目(2016KJA468) 安徽省高校大学生科研创新基金(201810367038)
关键词 三阴性乳腺癌 肿瘤转移 缝隙连接蛋白26 核转录因子-ΚB triple negative breast cancer tumor metastasis connexin 26 nuclear factor-κB
  • 相关文献

参考文献3

二级参考文献64

  • 1张瑰红,施达仁,梁晓曼,侯景辉,康苏娅,朱卫东,李晓兵,邵云,陈丽荣,周燕.显色原位杂交和免疫组织化学检测乳腺癌HER2/neu基因状况和蛋白表达的对照性研究[J].中华病理学杂志,2006,35(10):580-583. 被引量:29
  • 2<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 3Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer [ J]. J Clin Oncol, 2007, 25 (33) :5287-5312.
  • 4Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Chnical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[ Jl. J Clin Oncol, 2007, 25 ( 1 ) : 118- 145.
  • 5Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth faetor reeeptor 2 testing in breast eaneer: American Society of Clinical Oneology/College of American Pathologists clinical practice guideline update[J]. J Clin Oneol, 2013, 31 (31) :3997-4013.
  • 6Hanna WM, Kwok K. Chromogenic in-situ hybridization:a viable ahernative to fluorescence in-situ hybridization in the HER2 testing algorithm[J]. Mod Pathol, 2006, 19(4) :481-487.
  • 7Park K, Han S, Kim JY, et al. Silver-enhanced in situ hybridization as an alternative to fluorescence in situ hybridization for assaying HER2 amplification in clinical breast cancer [ J ]. J Breast Cancer, 2011, 14(4) :276-282.
  • 8Haines GK 3rd, Wiley E, Susnik B, et al. HER2 in well differentiated breast cancer: is testing necessary? [ J ]. Breast Cancer Res Treat, 2008, 112(3) :551-556.
  • 9Zhu X, Lu Y, Lu H, et al. Genetic alterations and protein expression of HER2 and chromosome 17 polysomy in breast cancer [J]. Hum Pathol, 2011,42(10) : 1499-1504.
  • 10Marchio C, Lambros MB, Gugliotta P, et al. Does chromosome 17 centromere copy number predict polysomy in breast cancer.9 A fluorescence in situ hybridization and microarray-based CGH analysis[ J]. J Pathol, 2009, 219( 1 ) : 16-24.

共引文献300

同被引文献64

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部